Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?

Abstract

Osteoarthritis (OA) is a common joint disease affecting humans and horses, resulting in significant morbidity, financial expense, and loss of athletic use. While the pathogenesis is incompletely understood, inflammation is considered crucial in the development and progression of the disease. Mesenchymal stromal cells (MSCs) have received increasing scientific attention for their anti-inflammatory, immunomodulatory, and pro-regenerative effects. However, there are concerns about their ability to become a commercially available therapeutic. Extracellular vesicles (EVs) are now recognized to play a crucial role in the therapeutic efficacy observed with MSCs and offer a potentially novel cell-free therapeutic that may negate many of the concerns with MSCs. There is evidence that EVs have profound anti-inflammatory, immunomodulatory, and pro-regenerative effects equal to or greater than the MSCs they are derived from in the treatment of OA. Most of these studies are in small animal models, limiting the translation of these results to humans. However, highly translational animal models are crucial for further understanding the efficacy of potential therapeutics and for close comparisons with humans. For this reason, the horse, which experiences the same gravitational impacts on joints similar to people, is a highly relevant large animal species for testing. The equine species has well-designed and validated OA models, and additionally, therapies can be further tested in naturally occurring OA to validate preclinical model testing. Therefore, the horse is a highly suitable model to increase our knowledge of the therapeutic potential of EVs.

Keywords

Extracellular vesicles / osteoarthritis / equine / animal models

References

[1] Safiri S,Smith E.Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017.Ann Rheum Dis2020;79:819-28

[2] Reed SR,Mc Ilwraith CW.Descriptive epidemiology of joint injuries in Thoroughbred racehorses in training.Equine Vet J2012;44:13-9

[3] Woolf AD.Global burden of osteoarthritis and musculoskeletal diseases.BMC Musculoskelet Disord2015;16 PMCID:PMC4674868

[4] Kloppenburg M.Osteoarthritis year in review 2019: epidemiology and therapy.Osteoarthr Cartil2020;28:242-8

[5] 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet2018;392:1789-858

[6] Mcilwraith CW.Traumatic arthritis and posttraumatic osteoarthritis in the horse. joint disease in the horse. Elsevier; 2016. p. 33-48.

[7] Wang X,Jin X.The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials.Osteoarthr Cartil2018;26:165-74

[8] Goldberg A,Soans J,Zaidi R.The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review.J Orthop Surg Res2017;12:39 PMCID:PMC5345159

[9] King NM.Ethical issues in stem cell research and therapy.Stem Cell Res Ther2014;5:85 PMCID:PMC4097842

[10] Loo SJQ.Advantages and challenges of stem cell therapy for osteoarthritis (Review).Biomed Rep2021;15:67 PMCID:PMC8212446

[11] Wang G,Liu W.Preclinical studies and clinical trials on mesenchymal stem cell therapy for knee osteoarthritis: a systematic review on models and cell doses.Int J Rheum Dis2022;25:532-62

[12] Doyle LM.Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis.Cells2019;8:727 PMCID:PMC6678302

[13] Kalra H,Mathivanan S.Focus on extracellular vesicles: introducing the next small big thing.Int J Mol Sci2016;17:170 PMCID:PMC4783904

[14] Lai RC,Lee MM.Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.Stem Cell Res2010;4:214-22

[15] Boere J,van de Lest CHA,Wauben MHM.Extracellular vesicles in joint disease and therapy.Front Immunol2018;9:2575 PMCID:PMC6240615

[16] Li K,Huang H.Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages.J Nanobiotechnology2022;20:38 PMCID:PMC8771624

[17] Zhang S,Lai RC,Hui JH.Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration.Osteoarthr Cartil2016;24:2135-40

[18] Tan SSH,Wong JRY.Mesenchymal stem cell exosomes for cartilage regeneration: a systematic review of preclinical in vivo studies.Tissue Eng Part B Rev2021;27:1-13

[19] McIlwraith CW,Kawcak CE.The horse as a model of naturally occurring osteoarthritis.Bone Joint Res2012;1:297-309 PMCID:PMC3626203

[20] Kawcak CE,Trotter GW.Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation.Am J Vet Res1997;58:1132-40

[21] Kawcak CE,Frisbie DD,Mcilwraith CW.Effects of osteochondral fragmentation and intra-articular triamcinolone acetonide treatment on subchondral bone in the equine carpus.Equine Vet J1998;30:66-71

[22] Seabaugh KA,Rao S,Frisbie DD.Examining the effects of the oral supplement biota orientalis in the osteochondral fragment-exercise model of osteoarthritis in the horse.Front Vet Sci2022;9:858391 PMCID:PMC9198577

[23] Frisbie DD,Baxter GM.Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise mode.Am J Vet Res1997;29:349-59

[24] Frisbie DD,Mcilwraith CW.A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee.Vet Comp Orthop Traumatol2006;19:142-6

[25] Bertoni L,Branly T.An experimentally induced osteoarthritis model in horses performed on both metacarpophalangeal and metatarsophalangeal joints: Technical, clinical, imaging, biochemical, macroscopic and microscopic characterization.PLoS One2020;15:e0235251 PMCID:PMC7316256

[26] Frisbie D,Robbins D,McIlwraith W.Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist protein.Gene Ther2002;9:12-20

[27] Cook JL,Kuroki K.Animal models of cartilage repair.Bone Joint Res2014;3:89-94 PMCID:PMC3974069

[28] Cope PJ,Li Y.Models of osteoarthritis: the good, the bad and the promising.Osteoarthr Cartil2019;27:230-9 PMCID:PMC6350005

[29] Wang Y,Wei Y.Osteoarthritis animal models for biomaterial-assisted osteochondral regeneration.Biomater Transl2022;3:264-79

[30] Shepherd DE.Thickness of human articular cartilage in joints of the lower limb.Ann Rheum Dis1999;58:27-34 PMCID:PMC1752762

[31] Ahern BJ,Boston R.Preclinical animal models in single site cartilage defect testing: a systematic review.Osteoarthr Cartil2009;17:705-13

[32] Broeckx SY,Buntinx S.Evaluation of an osteochondral fragment-groove procedure for induction of metacarpophalangeal joint osteoarthritis in horses.Am J Vet Res2019;80:246-58

[33] Frisbie DD,Billinghurst RC,McIlwraith CW.Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses.Osteoarthr Cartil2008;16:1196-204

[34] Kawcak CE,McIlwraith CW,Park RD.Evaluation of avocado and soybean unsaponifiable extracts for treatment of horses with experimentally induced osteoarthritis.Am J Vet Res2007;68:598-604

[35] Simmons E,Weisbrode S.Instability-induced osteoarthritis in the metacarpophalangeal joint of horses.Am J Vet Res1999;60:7-13

[36] Bolam CJ,Cruz A.Characterization of experimentally induced post-traumatic osteoarthritis in the medial femorotibial joint of horses.Am J Vet Res2006;67:433-47

[37] Boyce M,Carlson C,Merritt K.Non-terminal animal model of post-traumatic osteoarthritis induced by acute joint injury.Osteoarthr Cartil2013;21:746-55 PMCID:PMC3624059

[38] Delco ML,Talts JF.Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.Am J Sports Med2020;48:612-23

[39] Kamm J,Witte T.Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.Equine Vet J2010;42:693-9 PMCID:PMC4183755

[40] McIlwraith CW,Kawcak CE,Hurtig M.The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.Osteoarthr Cartil2010;18 Suppl 3:S93-105

[41] Foland JW,Trotter GW,Lamar CH.Effect of betamethasone and exercise on equine carpal joints with osteochondral fragments.Vet Surg1994;23:369-76

[42] Frisbie DD,McIlwraith CW,Powers BE.Effects of triamcinolone in an equine in vivo osteochondral fragment model.Equine Vet J1996;29:270

[43] Frisbie DD,Baxter GM.Effects of 6alpha-methylprednisolone acetate on an equine osteochondral fragment exercise model.Am J Vet Res1998;59:1619-28

[44] Frisbie DD,Werpy NM,Mcilwraith CW.Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.Am J Vet Res2007;68:290-6

[45] Kawcak CE,Werpy NM,McIlwraith CW.Effects of exercise vs experimental osteoarthritis on imaging outcomes.Osteoarthr Cartil2008;16:1519-25

[46] Frisbie DD,Mcilwraith CW.Evaluation of polysulfated glycosaminoglycan or sodium hyaluronan administered with experimentally induced osteoarthritis.Am J Vet Res2009;70:203-9

[47] Frisbie DD,McIlwraith CW.Evaluation of the effect of extracorporeal shock wave treatment on experimentally induced osteoarthritis in middle carpal joints of horses.Am J Vet Res2009;70:449-54

[48] Frisbie DD,Kawcak CE,McIlwraith CW.Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.J Orthop Res2009;27:1675-80

[49] Kawcak CE,McIlwraith CW.Effects of extracorporeal shock wave therapy and polysulfated glycosaminoglycan treatment on subchondral bone, serum biomarkers, and synovial fluid biomarkers in horses with induced osteoarthritis.Am J Vet Res2011;72:772-9

[50] McIlwraith CW,Kawcak CE.Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses.Am J Vet Res2012;73:628-33

[51] Donnell JR,King MR,Haussler KK.Comparison of subjective lameness evaluation, force platforms and an inertial-sensor system to identify mild lameness in an equine osteoarthritis model.Vet J2015;206:136-42

[52] Frisbie DD,Kawcak CE.Efficacy of intravenous administration of hyaluronan, sodium chondroitin sulfate, and N-acetyl-d-glucosamine for prevention or treatment of osteoarthritis in horses.Am J Vet Res2016;77:1064-70

[53] King MR,Kawcak CE.Biomechanical and histologic evaluation of the effects of underwater treadmill exercise on horses with experimentally induced osteoarthritis of the middle carpal joint.Am J Vet Res2017;78:558-69

[54] Frisbie D,Nelson B.In vivo assessment of anti nerve growth factor administration either systemically or locally using models of joint disease.Osteoarthr Cartil2017;25:S442

[55] Goldring MB.Inflammation in osteoarthritis.Curr Opin Rheumatol2011;23:471-8 PMCID:PMC3937875

[56] Brandt KD,Radin EL.Etiopathogenesis of osteoarthritis.Rheum Dis Clin North Am2008;34:531-59

[57] Lane NE,Hawker G.OARSI-FDA initiative: defining the disease state of osteoarthritis.Osteoarthr Cartil2011;19:478-82

[58] Loeser RF,Scanzello CR.Osteoarthritis: a disease of the joint as an organ.Arthritis Rheum2012;64:1697-707 PMCID:PMC3366018

[59] Wenham CY.The role of synovitis in osteoarthritis.Ther Adv Musculoskelet Dis2010;2:349-59 PMCID:PMC3383490

[60] Estrada McDermott J,Goodrich L.Role of innate immunity in initiation and progression of osteoarthritis, with emphasis on horses.Animals (Basel)2021;11:3247

[61] Chen Y,Huang Y.Macrophages in osteoarthritis: pathophysiology and therapeutics.Am J Transl Res2020;12:261-8 PMCID:PMC7013211

[62] Sellam J.The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.Nat Rev Rheumatol2010;6:625-35

[63] Sandell LJ.Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis.Arthritis Res2001;3:107-13 PMCID:PMC128887

[64] van Weeren PR.General anatomy and physiology of joints. Second Edi. Elsevier Inc.; 2015.

[65] Deyle GD,Matekel RL.Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program.Physical Therapy2005;85:1301-17

[66] Knutsen G,Ludvigsen TC.Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial.J Bone Joint Surg Am2004;86:455-64

[67] Zhu C,Qu X.Mesenchymal stem cells in osteoarthritis therapy: a review.Am J Transl Res2021;13:448-61

[68] Zanotto GM.Current joint therapy usage in equine practice: changes in the last 10 years.Equine Vet J2021;Epub ahead of print:

[69] Migliore A.Effectiveness and utility of hyaluronic acid in osteoarthritis.Clin Cases Miner Bone Metab2015;12:31-3 PMCID:PMC4469223

[70] Goodrich LR.Medical treatment of osteoarthritis in the horse - a review.Vet J2006;171:51-69

[71] van Galen G,Hyldahl Laursen S.Colonic health in hospitalized horses treated with non-steroidal anti-inflammatory drugs - a preliminary study.J Equine Vet Sci2021;101:103451

[72] Lazzaroni M.Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.Aliment Pharmacol Ther2004;20 Suppl 2:48-58

[73] Wernecke C,Dragoo JL.The effect of intra-articular corticosteroids on articular cartilage: a systematic review.Orthop J Sports Med2015;3:2325967115581163 PMCID:PMC4622344

[74] Chen J,Li R.Efficacy and safety of tanezumab on osteoarthritis knee and hip pains: a meta-analysis of randomized controlled trials.Pain Med2017;18:374-85

[75] Auw Yang KG,van Arkel ER.Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.Osteoarthr Cartil2008;16:498-505

[76] Nixon AJ,Lang HM.Disease-modifying osteoarthritis treatment with interleukin-1 receptor antagonist gene therapy in small and large animal models.Arthritis Rheumatol2018;70:1757-68

[77] Horwitz EM,Dominici M.International Society for Cellular TherapyClarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.Cytotherapy2005;7:393-5

[78] Dominici M,Mueller I.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.Cytotherapy2006;8:315-7

[79] Meirelles Lda S,Covas DT.Mechanisms involved in the therapeutic properties of mesenchymal stem cells.Cytokine Growth Factor Rev2009;20:419-27

[80] Toh WS,Pei M.Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration.Stem Cell Rev Rep2014;10:686-96

[81] Abd-elsayed A.Stem cells for the creatment of knee osteoarthritis: a comprehensive review.Pain Phys2018;1:229-42

[82] Maheshwer B,Paul K.Regenerative potential of mesenchymal stem cells for the treatment of knee osteoarthritis and chondral defects: a systematic review and meta-analysis.Arthroscopy2021;37:362-78

[83] Ferris DJ,Kisiday JD.Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.Vet Surg2014;43:255-65

[84] Broeckx SY,Suls M.Equine allogeneic chondrogenic induced mesenchymal stem cells are an effective treatment for degenerative joint disease in horses.Stem Cells Dev2019;28:410-22

[85] Fortier LA,Rickey EJ.Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model.J Bone Joint Surg Am2010;92:1927-37

[86] Baraniak PR.Stem cell paracrine actions and tissue regeneration.Regen Med2010;5:121-43 PMCID:PMC2833273

[87] van Buul GM,Bos PK.Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.Osteoarthr Cartil2012;20:1186-96

[88] Chen YC,Tan KP,Wang YH.Can mesenchymal stem cells and their conditioned medium assist inflammatory chondrocytes recovery?.PLoS One2018;13:e0205563

[89] Timmers L,Arslan F.Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium.Stem Cell Res2007;1:129-37

[90] Kim GB,Seo MS,Park WT.Mesenchymal stem cell-derived exosomes and their therapeutic potential for osteoarthritis.Biology (Basel)2021;10:285 PMCID:PMC8066608

[91] Mustonen AM.Extracellular vesicles and their potential significance in the pathogenesis and treatment of osteoarthritis.Pharmaceuticals (Basel)2021;14:315 PMCID:PMC8065796

[92] Barkholt L,Jekerle V.Risk of tumorigenicity in mesenchymal stromal cell-based therapies-bridging scientific observations and regulatory viewpoints.Cytotherapy2013;15:753-9

[93] Zhou T,Weng J.Challenges and advances in clinical applications of mesenchymal stromal cells.J Hematol Oncol2021;14:24

[94] Pelttari K,Steck E.Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice.Arthritis Rheum2006;54:3254-66

[95] Nicolas R.Isolation and analysis. The chromosomal proteins. Elsevier; 1982. p. 41-68.

[96] Gasser O,Miot S,Sanchez JC.Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils.Exp Cell Res2003;285:243-57

[97] Taylor RC,Martin SJ.Apoptosis: controlled demolition at the cellular level.Nat Rev Mol Cell Biol2008;9:231-41

[98] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[99] Zeng ZL.Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review.Biomater Transl2022;3:175-87

[100] Zhu Y,Zhao B.Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis.Stem Cell Res Ther2017;8:64

[101] Gorgun C,Reverberi D.Role of extracellular vesicles from adipose tissue- and bone marrow-mesenchymal stromal cells in endothelial proliferation and chondrogenesis.Stem Cells Transl Med2021;10:1680-95

[102] Capomaccio S,Bazzucchi C.Equine adipose-derived mesenchymal stromal cells release extracellular vesicles enclosing different subsets of small RNAs.Stem Cells Int2019;2019:4957806

[103] Arévalo-Turrubiarte M,Ponti G,Martignani E.Extracellular vesicles from equine mesenchymal stem cells decrease inflammation markers in chondrocytes in vitro.Equine Vet J2022;54:1133-43 PMCID:PMC9787580

[104] Tofiño-Vian M,Pérez Del Caz MD,Alcaraz MJ.Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes.Cell Physiol Biochem2018;47:11-25

[105] Cosenza S,Toupet K,Noël D.Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis.Sci Rep2017;7:16214 PMCID:PMC5701135

[106] Cosenza S,Maumus M.Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis.Theranostics2018;8:1399-410

[107] Capra E.The biological function of extracellular vesicles during fertilization, early embryo-maternal crosstalk and their involvement in reproduction: review and overview.Biomolecules2020;10:1510 PMCID:PMC7693816

[108] Lange-Consiglio A,Perrini C.MicroRNAs of equine amniotic mesenchymal cell-derived microvesicles and their involvement in anti-inflammatory processes.Cell Transplant2018;27:45-54

[109] Lange-Consiglio A,Corradetti B.Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.Cytotherapy2013;15:1011-20

[110] Liu H,Zhang T.Engineered bacterial extracellular vesicles for osteoporosis therapy.Chem Eng J2022;450:138309

[111] Liu H,Han Y,Geng Z.Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy.Theranostics2022;12:6576-94

[112] Yin H,Tian G.The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation.SSRN J2022;preprint

[113] Liang Y,Li X.Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy.ACS Appl Mater Interfaces2020;12:36938-47

[114] Gurung S,Touramanidou L.The exosome journey: from biogenesis to uptake and intracellular signalling.Cell Commun Signal2021;19:47 PMCID:PMC8063428

[115] Mulcahy LA,Carter DR.Routes and mechanisms of extracellular vesicle uptake.J Extracell Vesicles2014;3:24641 PMCID:PMC4122821

[116] Jeyaram A.Preservation and storage stability of extracellular vesicles for therapeutic applications.AAPS J2017;20:1 PMCID:PMC6582961

[117] Watson DC,Bergamaschi C.Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes.J Extracell Vesicles2018;7:1442088

[118] Paolini L,Costa M.Large-scale production of extracellular vesicles: report on the “massivEVs” ISEV workshop.J of Extracellular Bio2022;1

[119] Withrow J,Liu Y,Fulzele S.Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis.Arthritis Res Ther2016;18:286 PMCID:PMC5134070

[120] Murphy C,Hunter M.Emerging role of extracellular vesicles in musculoskeletal diseases.Mol Aspects Med2018;60:123-8

[121] Malda J,van de Lest CHA,Wauben MHM.Extracellular vesicles - new tool for joint repair and regeneration.Nat Rev Rheumatol2016;12:243-9 PMCID:PMC7116208

[122] Li JJ,Grau GE,Little CB.Stem Cell-Derived Extracellular Vesicles for Treating Joint Injury and Osteoarthritis.Nanomaterials (Basel)2019;9:261 PMCID:PMC6409698

[123] Ni Z,Chen H.The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis.Cell Death Dis2019;10:522

[124] Nakasa T,Kato T,Nakamura Y. Exosome derived from osteoarthritis cartilage induces catabolic factor gene expressions in synovium. ORS, Annual Meeting, San Francisco; 2016.

[125] Kato T,Ishitobi H.Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes.Arthritis Res Ther2014;16:R163 PMCID:PMC4261911

[126] He L,Xing J.Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis.Stem Cell Res Ther2020;11:276

[127] Hotham WE,Szu-Ting L.The anti-inflammatory effects of equine bone marrow stem cell-derived extracellular vesicles on autologous chondrocytes.Vet Rec Open2021;8:e22 PMCID:PMC8580791

[128] Vonk LA,Liv N.Mesenchymal stromal/stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro.Theranostics2018;8:906-20

[129] Hotham WE,Newell K,Henson F.The isolation and characterisation of equine bone marrow stem cell derived extracellular vesicles - evidence of an anti-inflammatory action on chondrocytes.Res Sq2020:preprint

[130] Liu Y,Wang Z,Zhang F.Exosomal KLF3-AS1 from hMSCs promoted cartilage repair and chondrocyte proliferation in osteoarthritis.Biochem J2018;475:3629-38

[131] Zhang S,Lai RC,Lim SK.MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity.Biomaterials2018;156:16-27

[132] Zhang S,Ren X.Mesenchymal stem cell exosomes promote functional osteochondral repair in a clinically relevant porcine model.Am J Sports Med2022;50:788-800

[133] Yang H,Huang W.The effect of human bone marrow mesenchymal stem cell-derived exosomes on cartilage repair in rabbits.Stem Cells Int2022;2022:5760107 PMCID:PMC9477595

[134] Wiklander OP,O’Loughlin A.Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.J Extracell Vesicles2015;4:26316 PMCID:PMC4405624

[135] Lee JY.Extracellular vesicles in regenerative medicine: potentials and challenges.Tissue Eng Regen Med2021;18:479-84 PMCID:PMC8300067

[136] Lener T,Aigner L.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.J Extracell Vesicles2015;4:30087 PMCID:PMC4698466